理肺益气汤干预治疗肺动脉高压气虚血瘀证的临床研究

《理肺益气汤干预治疗肺动脉高压气虚血瘀证的临床研究》由会员上传分享，免费在线阅读，更多相关内容在学术论文-天天文库。

1、提要目的：观察理肺益气汤对肺动脉高压气虚血瘀证的症状改善及超声改变。通过患者治疗前后的临床症状评分、肺动脉收缩压、心功能等指标的检测，探讨其临床应用价值。方法：将56例临床诊断为肺动脉高压气虚血瘀证的患者随机分为两组，其中12周为一个疗程，1个疗程后观察疗效。结果：经临床观察，治疗组在改善本病的症状，降低临床症状积分方面优于对照组（P<0.05）；在改善超声心动图、运动耐量、心功能学方面明显优于对照组（P<0.05）；并且在治疗过程中未发生不良反应。结论:临床观察表明理肺益气汤治疗肺动脉高压气虚血瘀证，可明显改善患者的临床症状，改善患者的超声心动图、

2、运动耐量、心功能，并且无明显不良反应，是一种治疗肺动脉高压气虚血瘀证的有效药物，值得进一步研究。关键词肺动脉高压；气虚血瘀证；理肺益气汤；临床研究ClinicalStudyonInterventionandTreatmentofQi-deficiency-blood-stasissyndromeinPulmonaryHypertensionByLifeiyiqitangSpeciality:InternalMedicineofTCMAuthor:FengBingTutor:ProfessorCaoBinAbstractObjective:Toinve

3、stigatethesymptommodifyingandultrasonicchangeofQi-deficiency-blood-stasissyndromeinpulmonaryhypertensionbyLifeiyiqitangBydetectingtheindexesthatthepatientscuredthefrontandback,suchasclinicalsymptomscores,PASPandcardiacfunction,toexploreitsc1inicalvalue.Methods:56patientsdiagnos

4、edQi-deficiency-blood-stasissyndromeinpulmonaryhypertensionwererandomlyclassifiedintotwogroups.28patientsweretreatedwithSildenafilandLifeiyiqitangintreatedgroup,othersweretreatedwithSildenafilincontrolgroup.Allofthegroupsweretreatedfour12weeksasacourse,takenfor1courses.Results:

5、Treatmentgroupcouldimprovethepatients’clinicalsymptomsandsigns,andtheeffectswerebetterthancontrolgroup(p<0.05).Inthesidesofimprovementofechocardiography，exercisetolerance，cardiacfunctionandsoon，theeffectsoftreatmentgroupwerebetterthancontrolgroup(P<0.05).Andthattherehadbeennoad

6、versereactioninthecourseoftreatment.Conclusion:ClinicalobservationhadprovedYifeilinggranulescansignificantlyimprovethepatient'sclinicalsymptoms,echocardiography，exercisetolerance，cardiacfunction.ItisaneffectivepreventionandtreatmentofQi-deficiency-blood-stasissyndromeinpulmonar

7、yhypertension.Itisworthstudyingdeeplyanddevelopingfurther.KeyWordsPulmonaryHypertension；Qi-deficiency-blood-stasissyndrome；Lifeiyiqitang;Clinicalresearch目录引言.........................................................................................................................

8、......1临床研究...........................................